Lung cancer mortality reduction linked to improvements in targeted therapies
1. In this retrospective cohort study, there was an observed decrease in mortality in non-small-cell lung cancer patients that corresponded ...
Tag: non-small cell lung cancer (NSCLC)
#VisualAbstract: Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in ...
Osimertinib associated with longer overall survival versus comparator EGFR-TKIs
1. After a 3-year follow-up to a phase 3 trial, the epidermal growth factor receptor-tyrosine kinase inhibitor osimertinib resulted in ...
Quick Take: Pembrolizumab Versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (KEYNOTE-042)
Pembrolizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1). Previous studies have shown that pembrolizumab is effective ...
Electronic health record clinical and genomic data provides relevant insights for non-small cell lung cancer
1. In patients with non-small cell lung cancer (NSCLC), an analysis of clinical and genomic data from routine care replicated ...
2 Minute Medicine Rewind April 8, 2019
Association of Racial Disparities With Access to Kidney Transplant After the Implementation of the New Kidney Allocation System There are ...
